Flight Centre Travel Group Limited (ASX:FLT) Releases Half-Year Results
Flight Centre Travel Group (ASX:FLT) reports a 7% increase in underlying PBT and a 10% rise in interim dividend for H1 FY25.
PointsBet Holdings Limited (ASX:PBH) Announces H1 FY25 Results
PointsBet Holdings Limited (ASX:PBH) reports a 6% revenue increase in H1 FY25 and announces its acquisition by MIXI.
NZME Limited (ASX:NZM) Announces 2024 Full Year Results
NZME Limited (ASX:NZM) reports a 2% increase in operating revenue for 2024, highlighting significant digital growth and strategic initiatives.
Steadfast Group (ASX:SDF) Announces 1H25 Results
Steadfast Group (ASX:SDF) reports a 20.9% NPAT increase and a 15.6% interim dividend rise for 1H25.
Euroz Hartleys Group Limited (ASX:EZL) Reports Half-Year Financial Results
Euroz Hartleys Group Limited (ASX:EZL) reports a 501% rise in net profit and declares a 2-cent interim dividend.
OncoSil Medical Ltd (ASX:OSL) Delivers Key Milestones and Financial Growth in H1 2025
OncoSil Medical Ltd (ASX:OSL) achieves significant clinical and financial milestones, expanding its global presence and enhancing its financial position in H1 2025.
Regal Investment Fund (ASX:RF1) Announces Half-Year Results and $104.4m Capital Raising
Regal Investment Fund (ASX:RF1) reports a 34% rise in operating profit and completes a $104.4 million capital raising for the half-year ended December 2024.
Acrux (ASX:ACR) Reports A$20M Revenue and Announces US Product Launches
Acrux (ASX:ACR) reports A$20 million revenue for FY23-FY24 and announces new US product launches, bolstering its presence in the pharmaceutical market.
Besra Gold Inc (ASX:BEZ) Addresses Unauthorised Communications
Besra Gold Inc (ASX:BEZ) addresses unauthorised statements from Quantum Metals, clarifying gold resource figures and operational integrity.
Archer Materials Limited (ASX:AXE) Enhances Biochip Feasibility and Advances Development Roadmap
Archer Materials Limited (ASX:AXE) improves Biochip’s potassium detection accuracy, advances to human blood testing, and plans regulatory engagements.